Green Bioactives appoints Thomas Nagy as chair of the board
Thomas Nagy
Green Bioactives Limited has appointed Thomas Nagy as non-executive chair of the company’s board of directors.
Thomas Nagy succeeds founder Gary Loake who will continues in the position of chief scientific officer.
Mr Nagy said: ”I am delighted to join Green Bioactives as the Chair of the Board at this exciting time of continued growth and expansion of the company. As a biotech industry veteran, I strongly believe Green Bioactives with its unique proprietary technology and strong team has what it takes to offer powerful new solutions for the global cosmetics, food ingredients, and nutraceuticals markets, making the world a better place. On the near term, the technology ultimately will secure a broad range of sustainable products for consumers and over the longer term, Green Bioactives will continue to play a leadership role in plant cell culture, helping to address a broad range of global sustainability issues.”
Mr Nagy brings a wealth of international experience in both large companies and SMEs. He currently holds board positions at the EVERY Company and GlycoSpot which follows on from his role in the executive management team at Novozymes A/S for more than a decade and then, most recently, setting up the BioInnovation Institute in Copenhagen.
His biotech experience and track record of fundraising will play a key part in guiding the Green Bioactives management team through its journey of growth and success.
David McElroy, CEO of Green Bioactives, commented: “It’s fantastic to have Thomas join the Green Bioactives team and we look forward to working with him to best realise Green Bioactives vision to improve lives with sustainable plant-derived natural products. Thomas has a wealth of valuable commercial and industrial experience international, especially around the scale up of cell-based production systems and more recently in the biobased products startup and venture space. We’re excited about continuing on our own growth journey with Thomas by our side.”
The appointment of Nagy demonstrates Green Bioactives commitment to excellence in the biotech arena and their desire to accelerate its expansion plans under strong leadership and high quality governance.
Thomas Nagy
Green Bioactives Limited has appointed Thomas Nagy as non-executive chair of the company’s board of directors.
Thomas Nagy succeeds founder Gary Loake who will continues in the position of chief scientific officer.
Mr Nagy said: ”I am delighted to join Green Bioactives as the Chair of the Board at this exciting time of continued growth and expansion of the company. As a biotech industry veteran, I strongly believe Green Bioactives with its unique proprietary technology and strong team has what it takes to offer powerful new solutions for the global cosmetics, food ingredients, and nutraceuticals markets, making the world a better place. On the near term, the technology ultimately will secure a broad range of sustainable products for consumers and over the longer term, Green Bioactives will continue to play a leadership role in plant cell culture, helping to address a broad range of global sustainability issues.”
Mr Nagy brings a wealth of international experience in both large companies and SMEs. He currently holds board positions at the EVERY Company and GlycoSpot which follows on from his role in the executive management team at Novozymes A/S for more than a decade and then, most recently, setting up the BioInnovation Institute in Copenhagen.
His biotech experience and track record of fundraising will play a key part in guiding the Green Bioactives management team through its journey of growth and success.
David McElroy, CEO of Green Bioactives, commented: “It’s fantastic to have Thomas join the Green Bioactives team and we look forward to working with him to best realise Green Bioactives vision to improve lives with sustainable plant-derived natural products. Thomas has a wealth of valuable commercial and industrial experience international, especially around the scale up of cell-based production systems and more recently in the biobased products startup and venture space. We’re excited about continuing on our own growth journey with Thomas by our side.”
The appointment of Nagy demonstrates Green Bioactives commitment to excellence in the biotech arena and their desire to accelerate its expansion plans under strong leadership and high quality governance.